🇺🇸 FDA
Patent

US 9296729

Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

granted A61KA61K31/517A61K49/0004

Quick answer

US patent 9296729 (Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K31/517, A61K49/0004, A61K51/00, A61P